Neighborhood invites you to join our panel around the topic of Microbiome to better understand the Microbiome. Our goal is to bring experienced and knowledgeable people on stage to share their thoughts with the audience.
- The link between the first scientific discoveries (INRA, Metagenopolis) and the birth of the first biotechs in France in the microbiome.
- The most obvious… and most hypothetical potential applications ;
- The state of knowledge around the microbiome (can everything be understood and cured thanks to the microbiome?) ;
- Regulatory/technical obstacles to the use of living biotherapies in clinics;
- The interest of financial investors and the pharmaceutical industry in the microbiome, etc.
Speakers
CEO at Enterome
Pierre Belichard has served as Chief Executive Officer since 2011 and as a member of the board of directors since 2011. Previously, Dr. Belichard served as Vice President of Mergers and Acquisitions and Business Development at Sanofi Ophthalmology from 2009 to 2011. Dr. Belichard was the Founder of Fovea Pharmaceuticals SA. and served as the Chief Operating Officer from 2005 to 2009. From 2002 to 2004, Dr. Belichard served as Vice President of Business Development at UroGene, S.A., a company acquired by Pierre Fabre in 2004. From 2000 to 2002, he served as head of European commercial operations at Ethypharm S.A. Dr. Belichard holds a Pharm.D. from Grenoble Faculty of Medicine and Pharmacy, Ph.D. from University Pierre and Marie Curie and an M.B.A. from INSEAD.
CEO of Seventure
Isabelle is CEO and Managing Partner and leads the Life Sciences team. Isabelle has a particular interest in the microbiome field and frequently gives lectures at conferences in this domain. She was the founder of Health for Life Capital fund, which primary focus is microbiome, in partnership with Danone and Novartis. Isabelle has a degree in Engineering from l’Ecole Centrale Paris and holds DECF and ISEB degrees and brings more than 25 years of international business development and finance experience in the pharmaceutical industry to the team.
CEO of LNC
Former researcher at the Institut Pasteur, Georges was Vice-President of Business Development & Intellectual Property and a member of the management team at Celyad. He previously served in various business development roles at Cellectis, Galapagos, ProStrakan and Sanofi-Aventis and led strategic alliance development consulting assignments. He holds a PhD in Microbiology from Pierre and Marie Curie University (France) and a master’s degree in Management and Strategy in the Health Industry from ESSEC Business School.
Clinical Development Expert
Doctor of Medecine, Dr Pierre Rimbaud is a renowned expert in the clinical development of therapies targeting the microbiome. He is co-founder of several biotech companies involved in the field of microbiome (MaaT Pharma, Enterome, etc.). He currently serves as strategic adviser for many companies.Last events
Event
Afterwork: Key Takeaways from JP Morgan’s Annual Healthcare Conference 2024 in Neighborhood
After two years of turmoil, tough financing, pipeline slimming and cost-cutting… prospects finally look brighter for the…
Event
The Neighborhood Showcase 2023 in Neighborhood
After a year of hard work on producing their development plans and regulatory strategy, Neighborhood’s Start-up Class of 2023 will…
Event
Afterwork: AI a revolution for Healthtech development and Investment? in Neighborhood
AI and in silico models are set to revolutionize biotech investments and transform the entire health innovation ecosystem, join us…
Event
Afterwork: Seen & Heard, Last Week, at JP Morgan’s Annual Healthcare Conference 2023 in Neighborhood
Rising interest rates have triggered a fall in market valuation, and an indirect brutal loss in appetite from VC and…
We'd love to get to know you
Join us, we offer you an extraordinary chance to learn, to develop and to be part of an exciting experience and team.
Tell us your story